General practitioners' perspectives on blood biomarkers for Alzheimer's disease.

ABSTRACT:

Background

Alzheimer's disease (AD) blood biomarkers could improve the diagnostic process for patients with cognitive complaints presenting to primary care. We investigated general practitioners' (GPs') perspectives on facilitating and hindering factors associated with the use and implementation of AD blood biomarkers.

Method

In this qualitative, semi-structured interview study, we used purposive sampling to recruit a heterogeneous group of 18 Dutch GPs. Qualitative data analysis of interview transcripts was based on the Theoretical Domains Framework.

Results

GPs believed that AD blood biomarkers could have both positive and negative consequences. Mentioned positive consequences included facilitating an accessible diagnostic process, clarity about the etiology, and li

SUBMITTER: Claessen T 

PROVIDER: S-EPMC12531899 | biostudies-literature | 2025 Oct-Dec

REPOSITORIES: biostudies-literature